SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-18-001475
Filing Date
2018-02-12
Accepted
2018-02-12 17:26:58
Documents
2
Period of Report
2018-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_151847440141543.html 3  
1 FORM 3 wf-form3_151847440141543.xml 3 1715
2 POA-GILL ex-24.htm EX-24 7188
  Complete submission text file 0001628280-18-001475.txt   10285
Mailing Address C/O NXSTAGE MEDICAL INC. (NXTM) 439 SOUTH UNION STREET, 5TH FLOOR LAWRENCE MA 01843
Business Address
GILL DAVID N (Reporting) CIK: 0001106519 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38381 | Film No.: 18597703

Mailing Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614
Business Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614 (949) 284-4555
Evolus, Inc. (Issuer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations